NRX Pharmaceuticals, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
NRX Pharmaceuticals, Inc. (NRXP) reported Adjustments to Additional Paid in Capital, Warrant Issued of $3.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-14
- NRX Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-03-31 was $3.25M.
- NRX Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-03-31 was $0.00.
- NRX Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-03-31 was $60.85M.
- NRX Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $3.25M.
- NRX Pharmaceuticals, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $60.85M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 3 month as first filed | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|
| 2025-12-31 | $3.25M 10-K · filed 2026-03-23 | ||
| 2025-03-31 | $3.25M 10-Q · filed 2026-08-14 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-11-14 | ||
| 2021-12-31 | $60.85M 10-K · filed 2023-03-31 | ||
| 2021-03-31 | $60.85M 10-Q · filed 2022-11-14 | $300.00K 10-Q · filed 2021-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |